Literature DB >> 16044070

Madarosis and facial alopecia presumed secondary to botulinum a toxin injections.

Dianne Kowing1.   

Abstract

PURPOSE: : Botulinum neurotoxins are considered relatively safe therapy for treatment of inappropriate muscle spasms. As seen in this report, undesirable consequences may result.
METHODS: : The author conducted a clinical interview and examination of the patient.
RESULTS: : Unilateral left-sided madarosis and facial alopecia were observed in a patient undergoing botulinum A toxin injections for the treatment of left oromandibular dystonia. The patient had started treatment 18 months previously. He received injections every 3 months in the left masseter and left temporalis muscles. He first noted loss of his left sideburn 8 months into treatment. After 10 months of treatment, he noted that he no longer needed to shave on the left side of his face. Eighteen months after receiving his first botulinum toxin injection, madarosis of the temporal aspect of the left lower lid was observed.
CONCLUSIONS: : This is the first case report documenting an idiosyncratic unilateral madarosis and facial alopecia as adverse side effects presumed secondary to botulinum A toxin injections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044070     DOI: 10.1097/01.opx.0000171332.53664.df

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  3 in total

1.  [Unilateral loss of eyebrows and repeated botulinum toxin injections: questionable correlation in essential blepharospasm].

Authors:  B Wabbels; B V Stanzel
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

Review 2.  Alopecia and Associated Toxic Agents: A Systematic Review.

Authors:  Vicky Yu; Margit Juhász; Audris Chiang; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2018-01-05

3.  Madarosis: a marker of many maladies.

Authors:  Annapurna Kumar; Kaliaperumal Karthikeyan
Journal:  Int J Trichology       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.